Showing results (41-50 of 247) with videos related to
Sort By:
Pageof 25
Blood|September 25, 2001
Interleukin-10 promotes the maintenance of antitumor CD8(+) T-cell effector function in situS Fujii, K Shimizu, T Shimizu, et al.Archives of Surgery (Chicago, Ill. : 1960)|December 1, 1986
Intraperitoneal administration of interleukin-2 in patients with cancerM T Lotze, M C Custer, S A RosenbergJournal of Immunology (Baltimore, Md. : 1950)|October 21, 1998
Rapid extracellular degradation of synthetic class I peptides by human dendritic cellsA A Amoscato, D A Prenovitz, M T LotzeAnnals of Internal Medicine|June 1, 1988
NIH conference. New approaches to the immunotherapy of cancer using interleukin-2S A Rosenberg, M T Lotze, J J MuléJournal of Immunology (Baltimore, Md. : 1950)|June 1, 1980
In vitro growth of cytotoxic human lymphocytes. II. Use of T cell growth factor (TCGF) to clone human T cellsM T Lotze, J L Strausser, S A RosenbergMethods in Molecular Medicine|February 5, 2014
Methods for generation of genetically modified fibroblasts for immunotherapy of cancerE M Elder, M T Lotze, T L WhitesideJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1988
Acute immunologic effects of interleukin-2 therapy in cancer patients: decreased delayed type hypersensitivity response and decreased proliferative response to soluble antigensE A Wiebke, S A Rosenberg, M T LotzeBehring Institute Mitteilungen|August 1, 1985
Problems with the isolation of lymphoid clones with reactivity to human tumorsM T Lotze, A A Rayner, E A GrimmSurgery|April 1, 1988
Heparin-induced thrombocytopenia and thromboembolism in the postoperative periodW E Rizzoni, K Miller, M Rick, et al.Cell Death and Differentiation|February 12, 2011
The Beclin 1 network regulates autophagy and apoptosisR Kang, H J Zeh, M T Lotze, et al.Pageof 25